WEBULL

Cutia Therapeutics' (HKG:2487) market cap surged HK$258m last week, private equity firms who have a lot riding on the company were rewarded

Simply Wall St · 4d ago

Key Insights

  • Significant control over Cutia Therapeutics by private equity firms implies that the general public has more power to influence management and governance-related decisions
  • The top 2 shareholders own 52% of the company
  • Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

A look at the shareholders of Cutia Therapeutics (HKG:2487) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are private equity firms with 60% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

As a result, private equity firms collectively scored the highest last week as the company hit HK$1.9b market cap following a 16% gain in the stock.

In the chart below, we zoom in on the different ownership groups of Cutia Therapeutics.

View our latest analysis for Cutia Therapeutics

ownership-breakdown
SEHK:2487 Ownership Breakdown January 8th 2026

What Does The Institutional Ownership Tell Us About Cutia Therapeutics?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Less than 5% of Cutia Therapeutics is held by institutional investors. This suggests that some funds have the company in their sights, but many have not yet bought shares in it. So if the company itself can improve over time, we may well see more institutional buyers in the future. When multiple institutional investors want to buy shares, we often see a rising share price. The past revenue trajectory (shown below) can be an indication of future growth, but there are no guarantees.

earnings-and-revenue-growth
SEHK:2487 Earnings and Revenue Growth January 8th 2026

Hedge funds don't have many shares in Cutia Therapeutics. 6 Dimensions Capital Limited is currently the largest shareholder, with 42% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 11% and 7.8%, of the shares outstanding, respectively. Additionally, the company's CEO Lele Zhang directly holds 4.8% of the total shares outstanding.

To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of Cutia Therapeutics

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

We can report that insiders do own shares in Cutia Therapeutics. In their own names, insiders own HK$112m worth of stock in the HK$1.9b company. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying.

General Public Ownership

The general public-- including retail investors -- own 23% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Private Equity Ownership

With a stake of 60%, private equity firms could influence the Cutia Therapeutics board. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Cutia Therapeutics better, we need to consider many other factors.

I always like to check for a history of revenue growth. You can too, by accessing this free chart of historic revenue and earnings in this detailed graph.

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.